R&D Systems™ Recombinant SARS-CoV-2 B.1.324.1 Spike (GCN4-IZ) Protein

Catalog No.	Quantity
10873CV100	100 μg

Catalog No. 10873CV100 Supplier R&D Systems™ Supplier No. 10873CV100

Description

His-tag. +E484K Point Mutation

Measured by its binding ability in a functional ELISA with Recombinant Human ACE-2 His-tag (Catalog # 933-ZN ).

Specifications

• Accession Number: YP_009724390.1
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 43740568
• Molecular Weight (g/mol): M.W.-observed: 140-160 kDa, under reducing conditions., M.W.-theroretical: 138 kDa
• Quantity: 100 μg
• Source: Human embryonic kidney cell, HEK293-derived sars-cov-2 Spike protein SARS-CoV-2 Spike (Val16 - Lys1211)(Glu484Lys, Ser494Pro, Asn501Tyr, Asp614Gly, Pro681His, Glu111Lys)(Arg682Ser, Arg685Ser, Lys986Pro, Val987Pro) (c-terminus) Accession # YP_009724390.1 GCN4-IZ 6-His tag N-terminus C-terminμs
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: 2019-nCoV S Protein, 2019-nCoV Spike, COVID-19 Spike, E2, Human coronavirus spike glycoprotein, Peplomer protein, S glycoprotein, S Protein, SARS-CoV-2, SARS-COV-2 S protein, SARS-COV-2 Spike glycoprotein, SARSCOV2 Spike protein, Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein, Spike glycoprotein, surface glycoprotein
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: SARS-CoV-2 Spike